T. Rowe Price Associates
CNCE

T. Rowe Price Associates’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

T. Rowe Price Associates’s Portfolio CNCE Stock Details CNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-39,705
Closed -$745K – 2547
2015
Q3 		$745K Buy
+39,705
New +$745K ﹤0.01% 1797